Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.
about
Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Preventing oxaliplatin-induced ...... investigational therapeutics.
@en
type
label
Preventing oxaliplatin-induced ...... investigational therapeutics.
@en
prefLabel
Preventing oxaliplatin-induced ...... investigational therapeutics.
@en
P2093
P2860
P1476
Preventing oxaliplatin-induced ...... f investigational therapeutics
@en
P2093
Andrew G Hill
Dean H Kilfoyle
Mark J McKeage
Michael B Jameson
P2860
P304
P356
10.1080/17425255.2016.1223625
P407
P577
2016-08-23T00:00:00Z